In vivo discovery of blood-brain barrier opening small molecules with FishNAP
This study introduces FishNAP, a high-throughput zebrafish platform that enabled the discovery of FDA-approved small molecules capable of transiently and reversibly opening the blood-brain barrier, a mechanism validated in mice to facilitate improved central nervous system drug delivery.